Molecular Oncology
Volume 3, Issue 1 , Pages 45-53 , February 2009

Expression and hypoxic up-regulation of neuroglobin in human glioblastoma cells

Received 5 September 2008 ,Revised 24 November 2008 ,Accepted 27 November 2008.

References 

  1. Allalunis-Turner MJ, Barron GM, Day RSD, Fulton DS, Urtasun RC. Radiosensitivity testing of human primary brain tumor specimens. Int. J. Radiat. Oncol. Biol. Phys. 1992;23:339–343
  2. Allalunis-Turner MJ, Barron GM, Day RSD, Dobler KD, Mirzayans R. Isolation of two cell lines from a human malignant glioma specimen differing in sensitivity to radiation and chemotherapeutic drugs. Radiat. Res. 1993;134:349–354
  3. Allalunis-Turner MJ, Franko AJ, Parliament MB. Modulation of oxygen consumption rate and vascular endothelial growth factor mRNA expression in human malignant glioma cells by hypoxia. Br. J. Cancer. 1999;80:104–109
  4. Bristow RG, Hill RP. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat. Rev. Cancer. 2008;8:180–192
  5. Brown JM, Wilson WR. Exploiting tumour hypoxia in cancer treatment. Nat. Rev. Cancer. 2004;4:437–447
  6. Brunori M, Vallone B. Neuroglobin, seven years after. Cell. Mol. Life Sci. 2007;64:1259–1268
  7. Burmester T, Weich B, Reinhardt S, Hankeln T. A vertebrate globin expressed in the brain. Nature. 2000;407:520–523
  8. Burmester T, Haberkamp M, Mitz S, Roesner A, Schmidt M, Ebner B, et al. Neuroglobin and cytoglobin: genes, proteins and evolution. IUBMB Life. 2004;56:703–707
  9. Burmester T, Hankeln T. Neuroglobin: a respiratory protein of the nervous system. News Physiol. Sci. 2004;19:110–113
  10. Chen G, Gharib TG, Huang CC, Taylor JM, Misek DE, Kardia SL, et al. Discordant protein and mRNA expression in lung adenocarcinomas. Mol. Cell. Proteomics. 2002;1:304–313
  11. Chen XQ, Qin LY, Zhang CG, Yang LT, Gao Z, Liu S, et al. Presence of neuroglobin in cultured astrocytes. Glia. 2005;50:182–186
  12. Dachs GU, Chaplin DJ. Microenvironmental control of gene expression: implications for tumor angiogenesis, progression, and metastasis. Semin. Radiat. Oncol. 1998;8:208–216
  13. Fernando MS, Simpson JE, Matthews F, Brayne C, Lewis CE, Barber R, et al White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke. 2006;37:1391–1398
  14. Fordel E, Geuens E, Dewilde S, Rottiers P, Carmeliet P, Grooten J, et al. Cytoglobin expression is upregulated in all tissues upon hypoxia: an in vitro and in vivo study by quantitative real-time PCR. Biochem. Biophys. Res. Commun. 2004;319:342–348
  15. Fordel E, Thijs L, Martinet W, Lenjou M, Laufs T, Van Bockstaele D, et al. Neuroglobin and cytoglobin overexpression protects human SH-SY5Y neuroblastoma cells against oxidative stress-induced cell death. Neurosci. Lett. 2006;410:146–151
  16. Fordel E, Thijs L, Martinet W, Schrijvers D, Moens L, Dewilde S. Anoxia or oxygen and glucose deprivation in SH-SY5Y cells: a step closer to the unraveling of neuroglobin and cytoglobin functions. Gene. 2007;398:114–122
  17. Fordel E, Thijs L, Moens L, Dewilde S. Neuroglobin and cytoglobin expression in mice. Evidence for a correlation with reactive oxygen species scavenging. FEBS J. 2007;274:1312–1317
  18. Fraser J, de Mello LV, Ward D, Rees HH, Williams DR, Fang Y, et al. Hypoxia-inducible myoglobin expression in nonmuscle tissues. Proc. Natl. Acad. Sci. USA. 2006;103:2977–2981
  19. Geuens E, Brouns I, Flamez D, Dewilde S, Timmermans JP, Moens L. A globin in the nucleus!. J. Biol. Chem. 2003;278:30417–30420
  20. Giuffre A, Moschetti T, Vallone B, Brunori M. Neuroglobin: enzymatic reduction and oxygen affinity. Biochem. Biophys. Res. Commun. 2008;367:893–898
  21. Greenberg DA, Jin K, Khan AA. Neuroglobin: an endogenous neuroprotectant. Curr. Opin. Pharmacol. 2008;8:20–24
  22. Hankeln T, Wystub S, Laufs T, Schmidt M, Gerlach F, Saaler-Reinhardt S, et al. The cellular and subcellular localization of neuroglobin and cytoglobin – a clue to their function?. IUBMB Life. 2004;56:671–679
  23. Hochachka PW, Buck LT, Doll CJ, Land SC. Unifying theory of hypoxia tolerance: molecular/metabolic defense and rescue mechanisms for surviving oxygen lack. Proc. Natl. Acad. Sci. USA. 1996;93:9493–9498
  24. Hockel M, Knoop C, Schlenger K, Vorndran B, Baussmann E, Mitze M, et al. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiother. Oncol. 1993;26:45–50
  25. Hockel M, Schlenger K, Hockel S, Aral B, Schaffer U, Vaupel P. Tumor hypoxia in pelvic recurrences of cervical cancer. Int. J. Cancer. 1998;79:365–369
  26. Holtkamp N, Afanasieva A, Elstner A, van Landeghem FK, Konneker M, Kuhn SA, et al. Brain slice invasion model reveals genes differentially regulated in glioma invasion. Biochem. Biophys. Res. Commun. 2005;336:1227–1233
  27. Hundahl C, Stoltenberg M, Fago A, Weber RE, Dewilde S, Fordel E, et al. Effects of short-term hypoxia on neuroglobin levels and localization in mouse brain tissues. Neuropathol. Appl. Neurobiol. 2005;31:610–617
  28. Hundahl C, Fago A, Dewilde S, Moens L, Hankeln T, Burmester T, et al. Oxygen binding properties of non-mammalian nerve globins. FEBS J. 2006;273:1323–1329
  29. Hundahl C, Kelsen J, Kjaer K, Ronn LC, Weber RE, Geuens E, et al. Does neuroglobin protect neurons from ischemic insult? A quantitative investigation of neuroglobin expression following transient MCAo in spontaneously hypertensive rats. Brain Res. 2006;1085:19–27
  30. Jin K, Mao XO, Xie L, Khan AA, Greenberg DA. Neuroglobin protects against nitric oxide toxicity. Neurosci. Lett. 2008;430:135–137
  31. Johnston AL, Lun X, Rahn JJ, Liacini A, Wang L, Hamilton MG, et al. The p75 neurotrophin receptor is a central regulator of glioma invasion. PLoS Biol. 2007;5:e212
  32. Khan AA, Sun Y, Jin K, Mao XO, Chen S, Ellerby LM, et al. A neuroglobin-overexpressing transgenic mouse. Gene. 2007;398:172–176
  33. Kleiter MM, Thrall DE, Malarkey DE, Ji X, Lee DY, Chou SC, et al. A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia marker. Int. J. Radiat. Oncol. Biol. Phys. 2006;64:592–602
  34. Koch CJ, Howell RL, Biaglow JE. Ascorbate anion potentiates cytotoxicity of nitro-aromatic compounds under hypoxic and anoxic conditions. Br. J. Cancer. 1979;39:321–329
  35. Laufs TL, Wystub S, Reuss S, Burmester T, Saaler-Reinhardt S, Hankeln T. Neuron-specific expression of neuroglobin in mammals. Neurosci. Lett. 2004;362:83–86
  36. Lees-Miller SP, Godbout R, Chan DW, Weinfeld M, Day RS, Barron GM, et al. Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science. 1995;267:1183–1185
  37. Li RC, Lee SK, Pouranfar F, Brittian KR, Clair HB, Row BW, et al. Hypoxia differentially regulates the expression of neuroglobin and cytoglobin in rat brain. Brain Res. 2006;1096:173–179
  38. Ljungkvist AS, Bussink J, Kaanders JH, van der Kogel AJ. Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers. Radiat. Res. 2007;167:127–145
  39. Mammen PP, Shelton JM, Goetsch SC, Williams SC, Richardson JA, Garry MG, et al. Neuroglobin, a novel member of the globin family, is expressed in focal regions of the brain. J. Histochem. Cytochem. 2002;50:1591–1598
  40. Mancuso M, Davidzon G, Kurlan RM, Tawil R, Bonilla E, Di Mauro S, et al. Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights. J. Neuropathol. Exp. Neurol. 2005;64:280–294
  41. Nordsmark M, Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother. Oncol. 2000;57:39–43
  42. Olive PL, Trotter T, Banath JP, Jackson SM, Le Riche J. Heterogeneity in human tumour hypoxic fraction using the comet assay. Br. J. Cancer. Suppl. 1996;27:S191–S195
  43. Ostojic J, Sakaguchi DS, de Lathouder Y, Hargrove MS, Trent JT, Kwon YH, et al. Neuroglobin and cytoglobin: oxygen-binding proteins in retinal neurons. Invest. Ophthalmol. Vis. Sci. 2006;47:1016–1023
  44. Parliament MB, Allalunis-Turner MJ, Franko AJ, Olive PL, Mandyam R, Santos C, et al. Vascular endothelial growth factor expression is independent of hypoxia in human malignant glioma spheroids and tumours. Br. J. Cancer. 2000;82:635–641
  45. Pesce A, Bolognesi M, Bocedi A, Ascenzi P, Dewilde S, Moens L, et al. Neuroglobin and cytoglobin. Fresh blood for the vertebrate globin family. EMBO Rep. 2002;3:1146–1151
  46. Powers JM. p53-mediated apoptosis, neuroglobin overexpression, and globin deposits in a patient with hereditary ferritinopathy. J. Neuropathol. Exp. Neurol. 2006;65:716–721
  47. Rayner BS, Duong TT, Myers SJ, Witting PK. Protective effect of a synthetic anti-oxidant on neuronal cell apoptosis resulting from experimental hypoxia re-oxygenation injury. J. Neurochem. 2006;97:211–221
  48. Rebetz J, Tian D, Persson A, Widegren B, Salford LG, Englund E, et al. Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma. PLoS ONE. 2008;3:e1936
  49. Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. N. Engl. J. Med. 2005;353:811–822
  50. Sato Y, Honda Y, Asoh T, Oizumi K, Ohshima Y, Honda E. Cerebrospinal fluid ferritin in glioblastoma: evidence for tumor synthesis. J. Neurooncol. 1998;40:47–50
  51. Schmidt-Kastner R, Haberkamp M, Schmitz C, Hankeln T, Burmester T. Neuroglobin mRNA expression after transient global brain ischemia and prolonged hypoxia in cell culture. Brain Res. 2006;1103:173–180
  52. Singh SK, Clarke ID, Hide T, Dirks PB. Cancer stem cells in nervous system tumors. Oncogene. 2004;23:7267–7273
  53. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature. 2004;432:396–401
  54. Stiles CD, Rowitch DH. Glioma stem cells: a midterm exam. Neuron. 2008;58:832–846
  55. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 2005;352:987–996
  56. Sun Y, Jin K, Mao XO, Zhu Y, Greenberg DA. Neuroglobin is up-regulated by and protects neurons from hypoxic-ischemic injury. Proc. Natl. Acad. Sci. U.S.A. 2001;98:15306–15311
  57. Sun Y, Jin K, Peel A, Mao XO, Xie L, Greenberg DA. Neuroglobin protects the brain from experimental stroke in vivo. Proc. Natl. Acad. Sci. U.S.A. 2003;100:3497–3500
  58. Turcotte ML, Parliament M, Franko A, Allalunis-Turner J. Variation in mitochondrial function in hypoxia-sensitive and hypoxia-tolerant human glioma cells. Br. J. Cancer. 2002;86:619–624
  59. Unwin RD, Smith DL, Blinco D, Wilson CL, Miller CJ, Evans CA, et al Quantitative proteomics reveals posttranslational control as a regulatory factor in primary hematopoietic stem cells. Blood. 2006;107:4687–4694
  60. Vaupel P, Schlenger K, Knoop C, Hockel M. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res. 1991;51:3316–3322
  61. Wilden J, Moore I. Histological Factors in the Prognosis of Malignant Glioma. Brain Oncology: Biology, Diagnosis and Therapy. Dordrecht: Martinus Nijhoff; 1987;pp. 243-247
  62. Wystub S, Ebner B, Fuchs C, Weich B, Burmester T, Hankeln T. Interspecies comparison of neuroglobin, cytoglobin and myoglobin: sequence evolution and candidate regulatory elements. Cytogenet. Genome Res. 2004;105:65–78
  63. Yaromina A, Zips D, Thames HD, Eicheler W, Krause M, Rosner A, et al Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies. Radiother. Oncol. 2006;81:122–129

PII: S1574-7891(08)00149-X

doi: 10.1016/j.molonc.2008.11.002

Molecular Oncology
Volume 3, Issue 1 , Pages 45-53 , February 2009

Article Tools

* Image Usage & Resolution